Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: A 3 year followup

Journal of Rheumatology

Volumn 23, Issue 6, 1996, Pages 995-1000

  Adachi, Jonathan D ^a,f   Bensen, William G ^a   Bianchi, Fernando ^a   Cividino, Alfred ^b   Pillersdorf, Sam ^c   Sebaldt, Rolf J ^d   Tugwell, Peter ^e   Gordon, Marilyn ^c   Steele, Marjorie ^c   Webber, Colin ^c   Goldsmith, Charles H ^c  

^a St Joseph's Hospital   (United States)

^b HENDERSON GENERAL HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d ST JOSEPH S HOSPITAL   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f NONE   (Canada)

Author keywords

CALCIUM; CORTICOSTEROIDS; OSTEOPOROSIS; VITAMIN D

Indexed keywords

CALCIUM; CORTICOSTEROID; PREDNISONE; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CALCIUM INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; VITAMIN INTAKE;

EID: 8944261594     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cushing H: The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 1932;50:137-95.
2. Hough S, Teitelbaum SL, Bergfeld MA, Avioli LV: Isolated skeletal involvement in Cushing's syndrome: Response to therapy. J Clin Endocrinol Metabol 1981;52:1033-8.
3. Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ: Histomorphometric profile, pathophysiology and reversibility of corticosteroid induced osteoporosis. Bone 1979;1:303-11.
4. Adinoff AD, Hollister JR: Steroid induced fractures and bone loss in subjects with asthma. N Eng J Med 1983;309:265-8.
5. Adachi JD, Bensen WG, Hodsman AB: Corticosteroid-induced osteoporosis. Semin Arthritis Rheum 1993;22:375-84.
6. Hahn TJ: Drug induced disorders of vitamin D and mineral metabolism. Clin Endocrinol Metabol 1980;9:107-29.
7. Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon WM: Effect of the flouride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Engl J Med 1982;306:446-50.
8. Hahn TJ, Hahn BH: Osteopenia in subjects with rheumatic diseases: Principles of diagnosis and therapy. Semin Arthritis Rheum 1976;6:165-88.
9. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH: Altered mineral metabolism in glucocorticoid induced osteopenia: Effect of 25-hydroxyvitamin D administration. J Clin Invest 1979;64:655-65.
10. Peck W, Gennari C, Raisz L, et al: Corticosteroids and bone. Calcif Tissue Int 1984;36:4-7.
11. Taves DR: Minimization: A new method of assigning subjects to treatment and control groups. Clin Pharmacol Ther 1974;15:443-53.
12. Adachi JD, Webber CE: The interchangeability of radioisotope and x-ray based measurement of bone mineral density. Br J Radiol 1991;64:217-20.
13. Dykman TR, Haralson KM, Gluck OS, et al: Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in subjects with rheumatic diseases. Arthritis Rheum 1984;27:1336-43.
14. Sambrook P, Birmingham J, Kelly P, et al: Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993;328:1747-52.